Clinical and laboratory evaluation of the hypercoagulable states.
In summary, every patient presenting with a new (or recurrent) thromboembolic event should be carefully assessed for potential predisposing factors. This starts with a thorough patient history and complete physical examination. If indicated, the clinical assessment is then used to guide the clinical laboratory evaluation for a potential hypercoagulable state. Identification of a specific hypercoagulable state, primary or secondary, is extremely important in the prognosis and therapeutic management of the individual patient.
Macik
B G
BG
Clinical Coagulation Service, Duke University Medical Center, Durham, North Carolina, USA.
Ortel
T L
TL
D001778:Blood Coagulation Disorders / Q000150:complications / Q000175:diagnosis*; D001780:Blood Coagulation Tests; D005260:Female; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D008297:Male; D010808:Physical Examination; D011247:Pregnancy; D013923:Thromboembolism / Q000209:etiology*